Health authorities warn public against counterfeit COVID-19 drugs

Job Manahan, ABS-CBN News

MANILA — Health authorities on Wednesday warned the public about the spread of fake COVID-19 oral treatments such as molnupiravir, advising them not to buy medicines from unauthorized sources, noting the possible health hazards of these drugs.In a statement, the Department of Health (DOH) said it received reports about &quot;possible&quot; counterfeit versions of the antiviral drug molnupiravir. &quot;Remember, there is no guarantee that molnupiravir sold from unauthorized sources are genuine and purchasing of such products may pose serious health risks for the consumer,&quot; the DOH statement read. &quot;It is your physician who will help secure your medicines and ensure they are authentic by referring you to authorized sellers,&quot; the agency added. The Food and Drug Administration (FDA) had previously released a <a href="https://www.fda.gov.ph/fda-advisory-no-2022-0005-public-health-warning-against-the-alleged-rampant-selling-of-molnupiravir-in-the-market/">statement </a>condemning the &quot;growing sales&quot; for the investigational COVID-19 treatment through &quot;unlicensed&quot; sellers. The drug regulator last month approved Molnarz&#x27;s molnupiravir for emergency use in treating COVID-19 cases.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/12/23/21/fda-oks-anti-viral-drug-molnupiravir-for-emergency-use">FDA approves emergency use of anti-viral drug molnupiravir</a></li></ul>The DOH said molnupiravir could only be used &quot;under the supervision of a licensed physician&quot; and in certain conditions.&quot;Molnupiravir is safe and effective when used in the correct patients and administered for no more than 5 days,&quot; the statement read. &quot;Using the drug improperly can cause harm, especially if it is used in the wrong target population, for longer than 5 days, or in patients who do not have confirmed COVID-19 infection,&quot; it added. The FDA reminded the public that the EUA prohibits the sale of molnupiravir commercially, which is why it is possible that some establishments selling it online are illicit sellers.&quot;Buying medicines in unlicensed establishments or over the internet can pose serious health risks. Furthermore, a medicine bought in an unlicensed establishment or online cannot be guaranteed as genuine and may contain no active ingredient, too much or too little active ingredient which may result in the condition/ailments not being treated correctly,&quot; the agency said. <div> PAXLOVID</div>Infectious disease expert Dr. Edsel Salvana, meanwhile, advised the public against the unauthorized use of Pfizer&#x27;s oral antiviral treatment Paxlovid.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/01/05/22/ph-in-talks-with-pfizer-to-procure-covid-treatment">Philippines in talks with Pfizer to procure COVID oral treatment: Duque</a></li>	<li><a href="https://news.abs-cbn.com/spotlight/11/05/21/pfizer-pill-cuts-risk-of-severe-covid-19-by-89">Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%</a></li></ul>Paxlovid is nearly 90 percent effective in preventing hospitalizations and death rates, and data suggested it retains its effectiveness against the omicron variant, Pfizer has said.The COVID-19 pill when used with viagra &quot;and similar erectile dysfunction (ED) drugs,&quot; Salvana said, could cause prolonged erection, among other things. &quot;Mixing Paxlovid with Viagra and similar erectile dysfunction (ED) drugs can result in unpredictably high levels of the ED drug resulting in low blood pressure, and unsafe levels of... prolonged erection,&quot; he said in a Facebook post.&quot;The ritonavir component of this drug has multiple potentially unsafe drug interactions, including interactions with some anticholesterol drugs (statins), steroids, rifampicin (used for tuberculosis)&quot; he added. The country is experiencing a fresh wave of new COVID-19 cases most likely driven by the omicron variant. <ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/01/19/22/ph-posts-22958-new-covid-cases-435pct-positivity-rate">Philippines reports 22,958 new COVID-19 cases</a></li></ul>On Wednesday, Philippines confirmed nearly 23,000 fresh infections, pushing active cases to over 270,000.<div> WATCH</div><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1884353" width="100%"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div>

The FDA previously released a statement condemning the 'growing sales' for the investigational COVID-19 treatment through 'unlicensed' sellers.

Health authorities warn public against counterfeit COVID-19 drugs

Entertainment

News

Metro.Style

Lifestyle

Sports

More

Traffic

Manila

Horoscope

News

Health authorities warn public against counterfeit COVID-19 drugs

Job Manahan,

ABS-CBN News

Published Jan 19, 2022 08:58 PM PHT

Read More:

Food and Drug Administration

coronavirus

COVID19

molnupiravir

FDA

DOH

Molnarz

Paxlovid

COVID-19 treatment

COVID-19 drugs

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.